Growth Metrics

Cross Country Healthcare (CCRN) Return on Sales (2016 - 2025)

Cross Country Healthcare's Return on Sales history spans 16 years, with the latest figure at 0.35% for Q4 2025.

  • For Q4 2025, Return on Sales fell 34.0% year-over-year to 0.35%; the TTM value through Dec 2025 reached 0.09%, down 8.0%, while the annual FY2025 figure was 0.09%, 8.0% down from the prior year.
  • Return on Sales reached 0.35% in Q4 2025 per CCRN's latest filing, down from 0.02% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.12% in Q4 2021 to a low of 0.35% in Q4 2025.
  • Average Return on Sales over 5 years is 0.01%, with a median of 0.03% recorded in 2021.
  • Peak YoY movement for Return on Sales: grew 10bps in 2021, then crashed -34bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.12% in 2021, then crashed by -52bps to 0.06% in 2022, then tumbled by -62bps to 0.02% in 2023, then plummeted by -155bps to 0.01% in 2024, then tumbled by -2793bps to 0.35% in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Return on Sales are 0.35% (Q4 2025), 0.02% (Q3 2025), and 0.02% (Q2 2025).